Bias in expert witness practice: sources, routes to expression and how to minimise it

SUMMARY The expert witness practice of psychiatrists is under constant scrutiny by the courts and, in the UK, the General Medical Council, as well as within appraisal and revalidation as part of a doctor's overall practice. Regulation and appraisal of expert witness practice must address not only technical competence, including demonstration of a real understanding of the interface between medicine and law, but also ethical probity, including in respect of bias, which is the most challenging appraisal focus. In psychiatry, there is much room for ‘values expression’, and therefore bias, in the offering of expert opinion. This article first describes various legal and psychological definitions of bias; then addresses the sources and routes to expression of bias within expert witness practice, viewed legally, psychologically and neuroscientifically. Finally, it proposes ways in which inevitable bias can be minimised by the individual practitioner.

Legal Tech in Legal Service: Challenging the Traditional Legal Landscape in Malaysia

Digital technologies are now extending its function to the legal profession. But the existence of these technologies otherwise known as legal tech or law tech is challenging the traditional legal profession. The nature of legal practice regulation in Malaysia and the United Kingdom (UK) permits only lawyers and authorised persons as legal service providers. As a result, the legal tech or law tech companies although able to facilitate the service in the legal profession are met with resistance and/or indifference. Should the traditional legal profession fear the invasion of this legal tech? This article aims to analyse the situation in Malaysia and the UK. It examines the impact of technology on legal service and legal profession in Malaysia and in the UK. The article also highlights the implication of this legal technology on the laws governing the legal profession in Malaysia. Through analyses of key Malaysian cases, the study finds that the Bar Council has the power to halt the operation of legal tech companies in providing any legal service in this country.As a result, the Bar has been criticised for being a hindrance to the development of legal tech in Malaysia. In contrast, the UK and the United States of America (US) have been very receptive to legal technology despite the exclusivity in the legal profession.

Community pharmacists’ involvement in ensuring patient safety

Burden of injuries to patients from adverse events is one of the top 10 causes of death and disability in the world; medication errors are a leading cause of injury. Most adverse events can be avoided. The objective of this work was to study involvement of community pharmacy professionals in ensuring patient safety in Armenia. Community pharmacists and technicians from all the regions of Armenia were asked to complete previously designed questionnaire. 353 professionals completed self-administered questionnaire. Data were analysed with SPSS statistical software, version 22.0. 87.8% of respondents reported that they observe prescribing errors when evaluating prescription at pharmacy. 69.4% of them indicate that the main error is wrong dose; 32.3% pointed medicines interactions; 32.0% - contraindications. Number of professionals from Yerevan, who indicated wrong dose, is higher than number of those from other regions (p < 0.001). Only 5.1% of participants register errors at pharmacy. 83.0% of pharmacy staff reported they always or often evaluate therapeutic aspects of prescriptions. 42.2% of respondents noted that, when patient is pressing, they never dispense a medicine without being sure that it is safe for patient; 27.5% do it very rarely. 76.8% of responders are sure their services ensure safe use of medicines by patients. 26.1% of pharmacy staff reported having SOPs at their pharmacy; 80.3% are interesting in introducing this strategy. Various prescription errors are observed by community pharmacists; however they are mainly not registered (there is no such requirement). In some cases prescriptions are not evaluated at community pharmacies. Approval of new standards for pharmacy practice seems to be beneficial. Recommendations are drafted for submitting to Ministry of Health. Key messages Involvement of pharmacy professionals in ensuring patient safety have to be increased. There is need for changes in pharmacy practice regulation leading to safer use of medicines by patients.

LWP update 1: assuring practice regulation

Over the next few months, we will be hearing more detail about the key recommendations contained in the recent report of the RCVS Legislation Working Party (LWP), from some of those who were directly involved in making them. To start, lay member of RCVS council Claire McLaughlan discusses the LWP’s recommendations around the principle of assuring practice regulation.

Lawyer disciplinary processes: an empirical study of solicitors’ misconduct cases in England and Wales in 2015

The Legal Services Act 2007 effected major changes in the disciplinary system for solicitors in England and Wales. Both the practice regulator, the Solicitors Regulation Authority, and a disciplinary body, the Solicitors Disciplinary Tribunal, were reconstituted as independent bodies and given new powers. Our concern is the impact of the Act on the disciplinary system for solicitors. Examination of this issue involves consideration of changes to regulatory institutions and the mechanics of practice regulation. Drawing on Foucault's notion of governmentality, empirical evidence drawn from disciplinary cases handled by the Solicitors Disciplinary Tribunal and the Solicitors Regulation Authority in 2015 is used to explore potentially different conceptions of discipline informing the work of the regulatory institutions. The conclusion considers the implications of our findings for the future of the professional disciplinary system.

Regulation Multiple: Pharmaceutical Trajectories and Modes of Control in the ASEAN

This article revisits the conceptualisation of pharmaceutical regulation. While States and multilateral organisations play a central part in devising rules, regulation as a social practice extends beyond their role. Domestic and international interests, geopolitics and spatial configurations, commercial and health considerations, governmental policies and individual behaviours and legal and illegal transactions all contribute to regulating the pharmaceutical milieu. This consideration expands the epistemological range of pharmaceutical regulation, which then appears as the assemblage of heterogeneous laws, rules and codes of conducts. The way in which these layers are connected forms what regulation actually is in practice. Regulation multiple thus appears as the product of tensions between harmonisation efforts and persistent diversity, as well as the result of interactions and overlaps between official regulation and unofficial regulatory practices. This article explores these tensions in the Southeast Asian pharmaceutical market along three themes: circuits and logistic regimes; control and attention to quality; bridges and harmonisations.

Part IV Motor Vehicle Distribution, 11 Motor Vehicle Distribution

This chapter addresses the specific block exemption regime that applies to the automotive industry. The relevant regime is contained in Regulation 461/2010. Different from past practice, Regulation 461/2010 closely resembles the general block exemption (Regulation 330/2010) and limits itself to adding certain hardcore restrictions applicable in the secondary markets. The chapter provides an overview of the impact of the block exemption from the perspective of the various stakeholders active in the sector. It then goes on to describe separately the block exemption principles governing the distribution of motor vehicles, the provision of after-sales services, and the distribution of spare parts.